Baotou Dongbao Bio-Tech Co.,Ltd.’s Net Profit Rose 719.3% in First Half of 2022

Baotou Dongbao Bio-Tech Co.,Ltd. (包头东宝生物技术股份有限公司) (300239.SZ) reported a net profit of 61.3 million yuan in the first half of 2022, up 719.3% year-on-year.

Meanwhile, the company posted 476.4 million yuan in revenue, up 72.2% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 526.3 million yuan in total liabilities, with a liability-to-asset ratio of 24.1%.